Global Health Data Exchange - Discover the World's Health Data

HPV Vaccination Cost Effectiveness Estimates

Nav

General Info
Provider 
Institute for Health Metrics and Evaluation (IHME)
Geography 
Afghanistan (AFG)
Albania (ALB)
Algeria (DZA)
Andorra (AND)
Angola (AGO)
Namibe
Antigua and Barbuda (ATG)
Argentina (ARG)
Armenia (ARM)
Australia (AUS)
Austria (AUT)
Azerbaijan (AZE)
Bahamas (BHS)
Bahrain (BHR)
Bangladesh (BGD)
Barbados (BRB)
Belarus (BLR)
Belgium (BEL)
Belize (BLZ)
Benin (BEN)
Bhutan (BTN)
Bolivia (BOL)
Bosnia and Herzegovina (BIH)
Botswana (BWA)
Brazil (BRA)
Brunei Darussalam (BRN)
Bulgaria (BGR)
Burkina Faso (BFA)
Burundi (BDI)
Cabo Verde (CPV)
Cambodia (KHM)
Cameroon (CMR)
Canada (CAN)
Central African Republic (CAF)
Chad (TCD)
Chile (CHL)
China (CHN)
Colombia (COL)
Comoros (COM)
Congo (COG)
Costa Rica (CRI)
Croatia (HRV)
Cuba (CUB)
Cyprus (CYP)
Czechia (CZE)
Côte d'Ivoire (CIV)
Democratic People's Republic of Korea (PRK)
Democratic Republic of the Congo (COD)
Denmark (DNK)
Djibouti (DJI)
Dominica (DMA)
Dominican Republic (DOM)
Ecuador (ECU)
Egypt (EGY)
El Salvador (SLV)
Equatorial Guinea (GNQ)
Eritrea (ERI)
Estonia (EST)
Eswatini (SWZ)
Ethiopia (ETH)
Fiji (FJI)
Finland (FIN)
France (FRA)
Gabon (GAB)
Gambia (GMB)
Georgia (GEO)
Germany (DEU)
Ghana (GHA)
Global
Greece (GRC)
Greenland (GRL)
Grenada (GRD)
Guatemala (GTM)
Guinea (GIN)
Guinea-Bissau (GNB)
Guyana (GUY)
Haiti (HTI)
Honduras (HND)
Hungary (HUN)
Iceland (ISL)
India (IND)
Indonesia (IDN)
Iran (Islamic Republic of) (IRN)
Iraq (IRQ)
Ireland (IRL)
Israel (ISR)
Italy (ITA)
Jamaica (JAM)
Japan (JPN)
Jordan (JOR)
Kazakhstan (KAZ)
Kenya (KEN)
Kiribati (KIR)
Kuwait (KWT)
Kyrgyzstan (KGZ)
Lao People's Democratic Republic (LAO)
Latvia (LVA)
Lebanon (LBN)
Lesotho (LSO)
Liberia (LBR)
Libya (LBY)
Lithuania (LTU)
Luxembourg (LUX)
Madagascar (MDG)
Malawi (MWI)
Malaysia (MYS)
Maldives (MDV)
Mali (MLI)
Malta (MLT)
Marshall Islands (MHL)
Mauritania (MRT)
Mauritius (MUS)
Mexico (MEX)
Micronesia (Federated States of) (FSM)
Mongolia (MNG)
Montenegro (MNE)
Morocco (MAR)
Mozambique (MOZ)
Myanmar (MMR)
Nepal (NPL)
Netherlands (NLD)
New Zealand (NZL)
Nicaragua (NIC)
Niger (NER)
Nigeria (NGA)
North Macedonia (MKD)
Norway (NOR)
Oman (OMN)
Pakistan (PAK)
Palestine (PSE)
Panama (PAN)
Papua New Guinea (PNG)
Paraguay (PRY)
Alto Paraguay
Peru (PER)
Philippines (PHL)
Poland (POL)
Portugal (PRT)
Qatar (QAT)
Republic of Korea (KOR)
Republic of Moldova (MDA)
Romania (ROU)
Russian Federation (RUS)
Rwanda (RWA)
Saint Lucia (LCA)
Saint Vincent and the Grenadines (VCT)
Samoa (WSM)
Sao Tome and Principe (STP)
Saudi Arabia (SAU)
Senegal (SEN)
Serbia (SRB)
Seychelles (SYC)
Sierra Leone (SLE)
Singapore (SGP)
Slovakia (SVK)
Slovenia (SVN)
Solomon Islands (SLB)
Somalia (SOM)
South Africa (ZAF)
South Sudan (SSD)
Spain (ESP)
Sri Lanka (LKA)
Sudan (SDN)
Suriname (SUR)
Sweden (SWE)
Switzerland (CHE)
Syrian Arab Republic (SYR)
Taiwan (Province of China) (TWN)
Tajikistan (TJK)
Thailand (THA)
Timor-Leste (TLS)
Togo (TGO)
Tonga (TON)
Trinidad and Tobago (TTO)
Tunisia (TUN)
Turkmenistan (TKM)
Türkiye (TUR)
Uganda (UGA)
Ukraine (UKR)
United Arab Emirates (ARE)
United Kingdom (GBR)
Bermuda
United Republic of Tanzania (TZA)
United States of America (USA)
American Samoa, Guam, Northern Mariana Islands, Puerto Rico, United States Virgin Islands
Uruguay (URY)
Uzbekistan (UZB)
Vanuatu (VUT)
Venezuela (Bolivarian Republic of) (VEN)
Viet Nam (VNM)
Yemen (YEM)
Zambia (ZMB)
Zimbabwe (ZWE)
View all
Coverage type 
Global
Time period covered 
12/2021 - 12/2021
Data type
Estimate
Summary 

The dataset contains predictions of the incremental cost-effectiveness ratios (ICERs) for the HPV vaccine in 195 countries. Predictions are based on meta-regression estimates of ICERs on three sets of independent variables (true variation measured by country characteristics, intervention characteristics, and bias variables). Data used in the meta-regression analysis are 613 ICERs from 75 studies in the Tufts University’s cost-effectiveness analysis registries, and additional extractions of ICERs for sensitivity analyses.

Keywords 
HPV, HPV vaccines, Health care costs
Related publications and visualizations 
Cost-effectiveness of HPV vaccination in 195 countries: A meta-regression analysis
GHDx Entry last modified on: Oct 7, 2024